SSA
NVS icon

Schonfeld Strategic Advisors’s Novartis NVS Stock Holding History

Schonfeld Strategic Advisors’s Portfolio NVS Stock Details NVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.45M Buy
+9,519
New +$1.46M 0.01% 938
2025
Q1 		– Sell
-62,418
Closed -$6.07M – 2415
2024
Q4 		$6.07M Buy
+62,418
New +$6.66M 0.04% 435
2023
Q3 		– Sell
-211,797
Closed -$21.4M – 2132
2023
Q2 		$21.4M Buy
211,797
+105,520
+99% +$10.6M 0.18% 163
2023
Q1 		$9.78M Buy
+106,277
New +$9.28M 0.09% 290
2022
Q4 		– Sell
-63,688
Closed -$4.84M – 2880
2022
Q3 		$4.84M Buy
+63,688
New +$5.28M 0.04% 537
2022
Q2 		– Sell
-144,915
Closed -$12.7M – 2861
2022
Q1 		$12.7M Buy
144,915
+136,015
+1,528% +$11.8M 0.11% 216
2021
Q4 		$779K Sell
8,900
-17,500
-66% -$1.45M 0.01% 1051
2021
Q3 		$2.16M Buy
+26,400
New +$2.38M 0.02% 687
2020
Q4 		– Sell
-3,320
Closed -$289K – 1778
2020
Q3 		$289K Buy
+3,320
New +$288K 0.01% 1109
2020
Q1 		– Sell
-58,107
Closed -$5.5M – 1400
2019
Q4 		$5.5M Buy
+58,107
New +$5.21M 0.13% 181
2019
Q2 		– Sell
-39,848
Closed -$3.43M – 1177
2019
Q1 		$3.43M Buy
+39,848
New +$3.2M 0.12% 230
2018
Q3 		– Sell
-20,758
Closed -$1.41M – 965
2018
Q2 		$1.41M Sell
20,758
-14,970
-42% -$1.03M 0.08% 334
2018
Q1 		$2.59M Buy
+35,728
New +$2.72M 0.19% 152
2017
Q4 		– Sell
-3,753
Closed -$289K – 838
2017
Q3 		$289K Sell
3,753
-2,403
-39% -$181K 0.03% 459
2017
Q2 		$460K Buy
+6,156
New +$436K 0.05% 404
2016
Q4 		– Sell
-23,888
Closed -$1.69M – 623
2016
Q3 		$1.69M Buy
+23,888
New +$1.74M 0.29% 91
2016
Q2 		– Sell
-5,394
Closed -$350K – 500
2016
Q1 		$350K Buy
+5,394
New +$367K 0.14% 193

Other funds holding NVS

Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Schonfeld Strategic Advisors's NVS Position: Q1 2026 in Review

Schonfeld Strategic Advisors opened a new position in Novartis (NVS) in Q1 2026: 9,519 shares worth $1.45M. The stake represents 0.01% of the portfolio and ranks #938 among its holdings. This is a return to the name: Schonfeld Strategic Advisors previously reported a position in NVS as recently as Q4 2024.

Schonfeld Strategic Advisors first reported a position in NVS in Q1 2016 and has held it in 17 quarters since. The position peaked at $21.4M in Q2 2023. 1,592 funds tracked by Wall St. Rank hold NVS as of Q1 2026.

  • Schonfeld Strategic Advisors held 9,519 shares of Novartis worth $1.45M as of Q1 2026.
  • Novartis was a new Schonfeld Strategic Advisors position in Q1 2026.
  • Novartis made up 0.01% of Schonfeld Strategic Advisors's portfolio in Q1 2026, its #938 holding.
  • Schonfeld Strategic Advisors first reported a position in Novartis in Q1 2016 and has held it in 17 quarters since.
  • Schonfeld Strategic Advisors's Novartis position peaked at $21.4M in Q2 2023.
  • 1,592 funds tracked by Wall St. Rank held Novartis as of Q1 2026.

Based on Schonfeld Strategic Advisors's 13F filing for Q1 2026, filed 15 May 2026.